Nu-Med Plus, Inc.
Nu-Med Plus, Inc.
Your view on NUMD
Overview
What the company does, where it operates, and who runs it.
About Nu-Med Plus, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- William R. Colvin
- Headquarters
- 455 East 500 South, Salt Lake City, UT, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- William R. Colvin
- Headquarters
- 455 East 500 South, Salt Lake City, UT, US
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide.
It develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications.
The company serves hospitals, health systems, and the medical community. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Nu-Med Plus, Inc., and the rating behind it. NUMD last traded at $0.02; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Nu-Med Plus, Inc.. Starting points for Nu-Med Plus, Inc.: beta -3.29 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Nu-Med Plus, Inc.. Nu-Med Plus, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Nu-Med Plus, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Nu-Med Plus, Inc.. Nu-Med Plus, Inc. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Nu-Med Plus, Inc. valued side by side against its closest peers. Nu-Med Plus, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Nu-Med Plus, Inc., and how their positions are changing. At a $1.3M market value, institutional positions materially move Nu-Med Plus, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Nu-Med Plus, Inc. executives and directors. Shares of Nu-Med Plus, Inc. have traded between $0.0075 and $0.14 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Nu-Med Plus, Inc.. Nu-Med Plus, Inc. is a $1.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Nu-Med Plus, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Nu-Med Plus, Inc.. Coverage tracks Nu-Med Plus, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.